Di Marco G, Chasan A, Boeckel G, Beul K, Pavenst xe4 dt H, Roth J, et al. Monocytes as Targets for Immunomodulation by Regional Citrate Anticoagulation. Int J Mol Sci. 2024;25: pubmed publisher

Mendoza Carrera F, Far xed as Basulto A, G xf3 mez Garc xed a E, Cort xe9 s Sanabria L, Cueto Manzano A, Rizo de la Torre L, et al. Association of Serum Fibroblast Growth Factor 23 and FGF23 Gene Variants with Chronic Kidney Disease in Patients with Type 2 Diabetes and Essential Hypertension. Arch Med Res. 2023;54:239-246 pubmed publisher

Chen H, Fang W, Chu S, Wang P, Lee C, Wu I, et al. Circulating Fibroblast Growth Factor-23 Levels Can Predict Rapid Kidney Function Decline in a Healthy Population: A Community-Based Study. Biomolecules. 2022;13: pubmed publisher

Chuang G, Liu P, Chyan T, Huang C, Huang Y, Lin C, et al. Genome-wide association study for circulating fibroblast growth factor 21 and 23. Sci Rep. 2020;10:14578 pubmed publisher

de Oliveira Neves F, Araújo C, de Freitas D, Arruda B, de Macêdo Filho L, Salles V, et al. Fibroblast growth factor 23, endothelium biomarkers and acute kidney injury in critically-ill patients. J Transl Med. 2019;17:121 pubmed publisher

Farías Basulto A, Martínez Ramírez H, Gómez García E, Cueto Manzano A, Cortes Sanabria L, Hernández Ramos L, et al. Circulating Levels of Soluble Klotho and Fibroblast Growth Factor 23 in Diabetic Patients and Its Association with Early Nephropathy. Arch Med Res. 2018;49:451-455 pubmed publisher

Deng G, Yang A, Wu J, Zhou J, Meng S, Zhu C, et al. The Value of Older Donors' Klotho Level in Predicting Recipients' Short-Term Renal Function. Med Sci Monit. 2018;24:7936-7943 pubmed publisher